Morgan Stanley’s Caribou Biosciences CRBU Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $418K | Sell |
331,481
-151,283
| -31% | -$191K | ﹤0.01% | 5545 |
|
|
2025
Q1 | $441K | Sell |
482,764
-2,266,833
| -82% | -$2.07M | ﹤0.01% | 5384 |
|
|
2024
Q4 | $4.37M | Buy |
2,749,597
+1,551,432
| +129% | +$2.47M | ﹤0.01% | 4110 |
|
|
2024
Q3 | $2.35M | Buy |
1,198,165
+579,678
| +94% | +$1.14M | ﹤0.01% | 4531 |
|
|
2024
Q2 | $1.01M | Buy |
618,487
+203,990
| +49% | +$335K | ﹤0.01% | 4950 |
|
|
2024
Q1 | $2.13M | Sell |
414,497
-1,795,129
| -81% | -$9.23M | ﹤0.01% | 4534 |
|
|
2023
Q4 | $12.7M | Buy |
2,209,626
+391,947
| +22% | +$2.25M | ﹤0.01% | 3729 |
|
|
2023
Q3 | $8.69M | Buy |
1,817,679
+550,946
| +43% | +$2.63M | ﹤0.01% | 3253 |
|
|
2023
Q2 | $5.38M | Buy |
1,266,733
+17,485
| +1% | +$74.3K | ﹤0.01% | 3713 |
|
|
2023
Q1 | $6.63M | Buy |
1,249,248
+20,081
| +2% | +$107K | ﹤0.01% | 3537 |
|
|
2022
Q4 | $7.72M | Buy |
1,229,167
+14,575
| +1% | +$91.5K | ﹤0.01% | 3326 |
|
|
2022
Q3 | $12.8M | Buy |
1,214,592
+571,409
| +89% | +$6.03M | ﹤0.01% | 2691 |
|
|
2022
Q2 | $3.49M | Buy |
643,183
+440,295
| +217% | +$2.39M | ﹤0.01% | 4080 |
|
|
2022
Q1 | $1.86M | Buy |
202,888
+99,820
| +97% | +$917K | ﹤0.01% | 4564 |
|
|
2021
Q4 | $1.56M | Buy |
103,068
+50,312
| +95% | +$760K | ﹤0.01% | 4763 |
|
|
2021
Q3 | $1.26M | Buy |
+52,756
| New | +$1.26M | ﹤0.01% | 4893 |
|